Corporate, Foundation and Government Supporters
The MitoCommunity is comprised of brave souls that take on extraordinary challenges every day because they live with mitochondrial disease. MitoCanada seeks out incredible people and partners to support our community. Check out some of our amazing supporters who are helping us improve the lives of Canadians living with, or at risk of developing mitochondrial disease, by supporting our education and awareness efforts and funding patient-focused research.
Because of their support, we are able to provide programs like MitoScholars/+ that help students impacted by mitochondrial disease pursue the education and careers they dream of. Thanks to our supporters, since 2022, MitoScholars/+ has provided fourteen $5,000 scholarships to mitostudents enrolled in Canadian universities, colleges or trade schools.
Our goal is to provide as many scholarships as possible to our community of post-secondary mitostudents. Jillian Grace Railton, one of our 2024 MitoScholars/+ shared:
“Getting a university degree is very important to me, and I plan to work hard and succeed! I’ve really learned to look at the bright side of life, and I want to help other people who are struggling to do the same.”
Read more about our MitoScholars/+ here.
Below is a list of our 2024 supporters.
Thank you!
Government Supporter
Supporter Spotlights
CIBC Miracle Day™ is a proud tradition that has helped to improve the lives of millions of children since it began in 1984. Every year, on the first Wednesday in December, CIBC Capital Markets team and CIBC Wood Gundy Investment Advisors donate their fees and commissions to help kids in need. Since its inception, CIBC Miracle Day has raised over $272 million for children’s charities globally.
CIBC Foundation, through CIBC Miracle Day, has donated to MitoCanada since 2018 to help Canadian children impacted by mitochondrial disease.
Ultragenyx is committed to supporting initiatives that provide impactful resources for the rare disease community, healthcare education, STEAM education, and local community organizations.
Since 2021, Ultragenyx has supported MitoCanada through generous donations totalling $148,000, supporting MitoScholars/+, Energy in Education and the Workplace, and MitoConnect programming. They have also sponsored our signature events, Walk NRoll 4 Mito in 2022, 2023 and 2024 and MitoSpin in 2023 and 2024. An enthusiastic group of employees joined MitoSpin in 2023.
“Ultragenyx was founded to advance innovative medicines for rare and ultrarare diseases that have never been treated before. We are delivering transformative therapies across multiple indications, and we have one of the most robust and diverse clinical pipelines in rare disease. Our focus is on doing the right things for patients both during development and commercialization to deliver on the promise of these therapies in a way that’s meaningful for rare disease communities.”
Emil D. Kakkis, M.D., Ph.D.
Chief Executive Officer and President